戻る
CervoMed Inc (CRVO)価格
CRVO 株価推移チャート
CRVO 収入
CervoMed Inc
$4.72
4.19%
$0.18
終値： Feb 13, 16:00:00 GMT-5
$4.7
-0.42%
$-0.01
アフターマーケット：Feb 13, 20:00:00 GMT-5
主要データ
前終値
$4.53
始値
$4.56
当日レンジ
$4.56 - $4.84
52週レンジ
$1.92 - $16.94
取引高
36.0K
平均取引高
75.2K
1株当たり利益(TTM)
-2.87
配当利回り
--
時価総額
$43.4M
CRVOとは何ですか？
CervoMed, Inc. is a clinical stage biotechnology company. The company is headquartered in Boston, Massachusetts and currently employs 15 full-time employees. The company went IPO on 2016-11-09. The firm is developing neflamapimod, an investigational, orally administered small molecule brain penetrant that inhibits p38 mitogen-activated protein kinase alpha. Neflamapimod has the potential to treat synaptic dysfunction, the reversible aspect of the underlying neurodegenerative processes that cause disease in Lewy bodies (DLB) and certain other neurological disorders. The company focuses on reducing the impact of inflammation in the brain, or neuroinflammation, which is a key factor in the manifestation of degenerative diseases of the brain, including DLB. Neflamapimod is being evaluated in the Company's ongoing RewinD-LB Trial, a Phase 2b trial in patients with DLB.